Cytological criteria of high‐grade epithelial atypia in the cyst fluid of pancreatic intraductal papillary mucinous neoplasms

MB Pitman, BA Centeno, ES Daglilar… - Cancer …, 2014 - Wiley Online Library
BACKGROUND The recognition of epithelial cells with high‐grade atypia (HGA) in the cyst
fluid of an intraductal papillary mucinous neoplasm (IPMN) identifies a cyst at high risk of …

The Sendai and Fukuoka consensus criteria for the management of branch duct IPMN-A meta-analysis on their accuracy

M Heckler, CW Michalski, S Schaefle, J Kaiser… - Pancreatology, 2017 - Elsevier
Introduction The risk of malignancy in branch duct intraductal papillary mucinous neoplasia
of the pancreas (BD-IPMN) is controversially debated. An increasing number of studies …

Predicting dysplasia and invasive carcinoma in intraductal papillary mucinous neoplasms of the pancreas: development of a preoperative nomogram

C Correa-Gallego, R Do, J LaFemina, M Gonen… - Annals of surgical …, 2013 - Springer
Background Clinical decision making for patients with intraductal papillary mucinous
neoplasms (IPMN) of the pancreas is challenging. Even with strict criteria for resection, most …

Pancreatic ductal adenocarcinomas associated with intraductal papillary mucinous neoplasms (IPMNs) versus pseudo-IPMNs: relative frequency, clinicopathologic …

T Muraki, KT Jang, MD Reid, B Pehlivanoglu… - Modern …, 2022 - nature.com
The literature is highly conflicted on what percentage of pancreatic ductal adenocarcinomas
(PDACs) arise in association with intraductal papillary mucinous neoplasms (IPMNs). Some …

Pancreatic cysts and guidelines

JJ Farrell - Digestive diseases and sciences, 2017 - Springer
Pancreatic cysts, especially incidental asymptomatic ones seen on noninvasive imaging
such as CT or MR imaging, remain a clinical challenge. The etiology of such cysts may …

Sendai and Fukuoka consensus guidelines identify advanced neoplasia in patients with suspected mucinous cystic neoplasms of the pancreas

P Kaimakliotis, B Riff, K Pourmand… - Clinical …, 2015 - Elsevier
Background & Aims Little is known about whether the 2006 Sendai guidelines or 2012
Fukuoka guidelines are being used to determine the level of risk posed by suspected …

Surgical overtreatment of pancreatic intraductal papillary mucinous neoplasms: Do the 2017 International Consensus Guidelines improve clinical decision making?

JM Sharib, AL Fonseca, DS Swords, K Jaradeh… - Surgery, 2018 - Elsevier
Background Significant overtreatment of intraductal papillary mucinous neoplasms can be
attributed to low specificity of the current International Consensus Guidelines as well as …

Branch-duct intraductal papillary mucinous neoplasm (IPMN): Are cyst volumetry and other novel imaging features able to improve malignancy prediction compared to …

RM Pozzi Mucelli, CF Moro, M Del Chiaro… - European …, 2022 - Springer
Objectives Current guidelines base the management of intraductal papillary mucinous
neoplasms (IPMN) on several well-established resection criteria (RC), including cyst size …

Cost-effectiveness of consensus guideline based management of pancreatic cysts: The sensitivity and specificity required for guidelines to be cost-effective

J Sharib, L Esserman, EJ Koay, A Maitra, Y Shen… - Surgery, 2020 - Elsevier
Background Detection of cystic lesions of the pancreas has outpaced our ability to stratify
low-grade cystic lesions from those at greater risk for pancreatic cancer, raising a concern …

Clinical management and surgical decision-making of IPMN of the pancreas

M Tanaka - Pancreatic Cancer: Methods and Protocols, 2019 - Springer
Intraductal papillary mucinous neoplasm (IPMN) is the most common pancreatic cystic
neoplasm (PCN). The increased attention to IPMN is due to its unique features of malignant …